FDA released a safety communication on January 21, 2015 regarding the use of bone graft substitutes containing recombinant proteins or synthetic peptides in patients under age 18. In response to this communication, the warning for the PepGen products will be updated to include a statement indicating product is not for use in patients under the age of 18.